Skip to content
  • Home
  • About Us
  • Pioneering Approach
  • ADC Platform
  • Clinical Trials
  • News and Publications
  • Collaborations
  • Shareholders
  • Contact
  • English
  • Español
  • Home
  • About Us
  • Pioneering Approach
  • ADC Platform
  • Clinical Trials
  • News and Publications
  • Collaborations
  • Shareholders
  • Contact
  • English
  • Español
  • Home
  • About Us
  • Pioneering Approach
  • ADC Platform
  • Clinical Trials
  • News and Publications
  • Collaborations
  • Shareholders
  • Contact
  • English
  • Español
  • Home
  • About Us
  • Pioneering Approach
  • ADC Platform
  • Clinical Trials
  • News and Publications
  • Collaborations
  • Shareholders
  • Contact
  • English
  • Español

Oncomatryx at BioEquity Europe 2024, Donostia-San Sebastián

July 21, 2026May 9, 2024 by OMTX

1715263405275

From May 12th to 14th, Oncomatryx Biopharma He will attend BioEquity Europe 2024 in Donostia-San Sebastián.

We look forward to meeting you at BioEquity and making the most of this valuable opportunity to network and learn.

Categories Events, NEWS
Oncomatryx acquires an Austrian company to consolidate its drugs against the tumor microenvironment
Oncomatryx at BIO 2024, San Diego
Linkedin X-twitter Youtube

This company is capitalized by INNVIERTE, AN INVESTMENT PROGRAM OF CDTI, E.P.E

Menu
  • About us
  • Pioneering approach
  • ADC Platform
  • Clinical trials
  • News and publications
  • Contact
Legal
  • Cookie policy
  • Terms of use
  • Privacy Policy
Contact us
  • Parque Tecnológico de Bizkaia 801B – 2P
  • 48160 Derio. Bizkaia. SPAIN
  • +34 946 087 037
 
If you prefer, you can send us an email at: info@oncomatryx.com
 
Managing consent

To offer the best experiences, we use technologies such as cookies to store and/or access information from your device. Consent to these technologies allows us to process data such as browsing behavior or the unique identifiers of this site. Refusing or withdrawing consent may negatively affect certain features and functions.

Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The storage or technical access is used exclusively for anonymous statistical purposes. Without a judicial requirement, voluntary compliance by your Internet service provider or additional records from a third party, the information stored or retrieved for this purpose cannot normally be used to identify you.
Marketing
The technical storage or access is necessary to create user profiles in order to send advertising, or to track the user on a website or across websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
See preferences
  • {title}
  • {title}
  • {title}